1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Glasdegib
Trade Name:
Daurismo
Manufacturer/Distributor:
Pfizer Canada
Classification:
Antineoplastic agent
ATC Class:
L01XX64 - glasdegib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/04/27
Date Marketed in Canada (yyyy/mm/dd):
2020/08/10
Presentation:
Tablet: 25 mg. DIN: 02498472
Tablet: 100 mg. DIN: 02498480
Comments:
For the treatment of newly diagnosed and previously untreated acute myeloid leukemia (AML) in adult patients who are age ≥75 years or who are not eligible to receive intensive induction chemotherapy (in combination with low-dose cytarabine).
Back to:
Drug Product Listings 
